Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis
One of the new experimental trends in pharmacotherapy of sepsis is the use of C1-esterase inhibitor (C1I) from the group of immunobiological agents influencing the complement system. An open prospective study on the safety and efficacy of C1I revealed its positive effect on the death rate among the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849244586288873472 |
|---|---|
| author | N. B. Lazareva A. A. Igonin |
| author_facet | N. B. Lazareva A. A. Igonin |
| author_sort | N. B. Lazareva |
| collection | DOAJ |
| description | One of the new experimental trends in pharmacotherapy of sepsis is the use of C1-esterase inhibitor (C1I) from the group of immunobiological agents influencing the complement system. An open prospective study on the safety and efficacy of C1I revealed its positive effect on the death rate among the patients with sepsis. In a dose of 12000 IU, C1I had a significant inhibitory action on the complement system activity, as well as an antiinflammatory effect by blocking the complement-dependent link in the systemic inflammation. The adverse and significant adverse events were not associated with the use of C1I. |
| format | Article |
| id | doaj-art-0e793e1ce54246f1b05b58e423760fb1 |
| institution | Kabale University |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2020-05-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-0e793e1ce54246f1b05b58e423760fb12025-08-20T03:59:08ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01541-24245203Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with SepsisN. B. Lazareva0A. A. Igonin1I.M. Sechenov Moscow Medical AcademyI.M. Sechenov Moscow Medical AcademyOne of the new experimental trends in pharmacotherapy of sepsis is the use of C1-esterase inhibitor (C1I) from the group of immunobiological agents influencing the complement system. An open prospective study on the safety and efficacy of C1I revealed its positive effect on the death rate among the patients with sepsis. In a dose of 12000 IU, C1I had a significant inhibitory action on the complement system activity, as well as an antiinflammatory effect by blocking the complement-dependent link in the systemic inflammation. The adverse and significant adverse events were not associated with the use of C1I.https://www.antibiotics-chemotherapy.ru/jour/article/view/204sepsiscl-esterase inhibitorsafetyefficacy |
| spellingShingle | N. B. Lazareva A. A. Igonin Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis Антибиотики и Химиотерапия sepsis cl-esterase inhibitor safety efficacy |
| title | Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis |
| title_full | Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis |
| title_fullStr | Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis |
| title_full_unstemmed | Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis |
| title_short | Safety and Efficacy of Pure Human Cl-Esterase Inhibitor in the Treatment of Patients with Sepsis |
| title_sort | safety and efficacy of pure human cl esterase inhibitor in the treatment of patients with sepsis |
| topic | sepsis cl-esterase inhibitor safety efficacy |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/204 |
| work_keys_str_mv | AT nblazareva safetyandefficacyofpurehumanclesteraseinhibitorinthetreatmentofpatientswithsepsis AT aaigonin safetyandefficacyofpurehumanclesteraseinhibitorinthetreatmentofpatientswithsepsis |